[Na+/Ca2+ exchanger (NCX1) and cardiovascular disease]

Nihon Yakurigaku Zasshi. 2007 Apr;129(4):262-5. doi: 10.1254/fpj.129.262.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Aniline Compounds / therapeutic use
  • Animals
  • Calcium Signaling / physiology
  • Cardiovascular Diseases / etiology*
  • Humans
  • Hypertension / etiology
  • Kidney / blood supply
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / etiology
  • Phenyl Ethers / therapeutic use
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / etiology
  • Sodium Chloride, Dietary / adverse effects
  • Sodium-Calcium Exchanger / antagonists & inhibitors
  • Sodium-Calcium Exchanger / genetics
  • Sodium-Calcium Exchanger / physiology*
  • Thiourea / analogs & derivatives
  • Thiourea / therapeutic use

Substances

  • 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate
  • Aniline Compounds
  • Phenyl Ethers
  • SEA 0400
  • Sodium Chloride, Dietary
  • Sodium-Calcium Exchanger
  • sodium-calcium exchanger 1
  • Thiourea